PubMed

Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis.

Wong JB, Koff RS.

Ann Intern Med. 2000 Nov 7;133(9):665-75.PMID: 11074899 [PubMed - indexed for MEDLINE]Related articlesFree article

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.

Wright M, Grieve R, Roberts J, Main J, Thomas HC; UK Mild Hepatitis C Trial Investigators.

Health Technol Assess. 2006 Jul;10(21):1-113, iii.PMID: 16750059 [PubMed - indexed for MEDLINE]Related articlesFree article

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.

Wong JB, Bennett WG, Koff RS, Pauker SG.

JAMA. 1998 Dec 23-30;280(24):2088-93.PMID: 9875876 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ.

JAMA. 2003 Jul 9;290(2):228-37.PMID: 12851278 [PubMed - indexed for MEDLINE]Related articlesFree article

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL.

Ann Intern Med. 1997 Nov 15;127(10):855-65.PMID: 9382363 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB; German Hepatitis C Model (GEHMO) Group; International Hepatitis Interventional Therapy (IHIT) Group.

Gut. 2003 Mar;52(3):425-32.PMID: 12584228 [PubMed - indexed for MEDLINE]Related articlesFree article

Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness.

Wong JB.

Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):238-42.PMID: 9658620 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Advances in the treatment of hepatitis C.

Lawrence SP.

Adv Intern Med. 2000;45:65-105. Review.PMID: 10635046 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.

Grieve R, Roberts J, Wright M, Sweeting M, DeAngelis D, Rosenberg W, Bassendine M, Main J, Thomas H.

Gut. 2006 Sep;55(9):1332-8. Epub 2005 Jun 30.PMID: 15994216 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Wong JB, Poynard T, Ling MH, Albrecht JK, Pauker SG.

Am J Gastroenterol. 2000 Jun;95(6):1524-30.PMID: 10894590 [PubMed - indexed for MEDLINE]Related articles

The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.

Hornberger J, Farci P, Prati D, Zeuzem S, Green J, Patel KK.

J Viral Hepat. 2006 Jun;13(6):377-86.PMID: 16842440 [PubMed - indexed for MEDLINE]Related articles

Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness.

Kuehne FC, Bethe U, Freedberg K, Goldie SJ.

Arch Intern Med. 2002 Dec 9-23;162(22):2545-56.PMID: 12456226 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

Yuan Y, Iloeje UH, Hay J, Saab S.

J Manag Care Pharm. 2008 Jan-Feb;14(1):21-33.PMID: 18240879 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.

Stein K, Rosenberg W, Wong J.

Gut. 2002 Feb;50(2):253-8.PMID: 11788569 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden.

Sennfält K, Reichard O, Hultkrantz R, Wong JB, Jonsson D.

Scand J Gastroenterol. 2001 Aug;36(8):870-6.PMID: 11495084 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.

Sullivan SD, Jensen DM, Bernstein DE, Hassanein TI, Foster GR, Lee SS, Cheinquer H, Craxi A, Cooksley G, Klaskala W, Pettit K, Patel KK, Green J.

Am J Gastroenterol. 2004 Aug;99(8):1490-6.PMID: 15307866 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C.

Buti M, Casado MA, Fosbrook L, Wong JB, Esteban R.

J Hepatol. 2000 Oct;33(4):651-8.PMID: 11059872 [PubMed - indexed for MEDLINE]Related articles

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.PMID: 15461877 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

Rothberg MB, Bellantonio S, Rose DN.

Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9.PMID: 12965940 [PubMed - indexed for MEDLINE]Related articlesFree article